These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Factors predicting response to dopaminergic treatment for resting tremor of Parkinson's disease. Sung YH, Chung SJ, Kim SR, Lee MC. Mov Disord; 2008 Jan; 23(1):137-40. PubMed ID: 17987649 [Abstract] [Full Text] [Related]
3. Latency of re-emergent tremor in Parkinson's disease is influenced by levodopa. Wilken M, Rossi MD, Rivero AD, Hallett M, Merello M. Parkinsonism Relat Disord; 2019 Apr; 61():166-169. PubMed ID: 30348494 [Abstract] [Full Text] [Related]
8. Non-dopaminergic treatments for motor control in Parkinson's disease. Fox SH. Drugs; 2013 Sep; 73(13):1405-15. PubMed ID: 23917951 [Abstract] [Full Text] [Related]
10. Effects of dopamine on reinforcement learning in Parkinson's disease depend on motor phenotype. van Nuland AJ, Helmich RC, Dirkx MF, Zach H, Toni I, Cools R, den Ouden HEM. Brain; 2020 Dec 05; 143(11):3422-3434. PubMed ID: 33147621 [Abstract] [Full Text] [Related]
11. [Tremor-dominant form of Parkinson's disease]. Zalyalova ZA, Katunina EA, Pokhabov DV, Munasipova SE, Ermakova MM. Zh Nevrol Psikhiatr Im S S Korsakova; 2024 Dec 05; 124(4):28-35. PubMed ID: 38676674 [Abstract] [Full Text] [Related]
13. [Pharmacological treatment of parkinsonian tremor]. Yokochi F. Nihon Rinsho; 2000 Oct 05; 58(10):2091-5. PubMed ID: 11068452 [Abstract] [Full Text] [Related]
14. Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease. Stocchi F, Rabey JM. Eur J Neurol; 2011 Dec 05; 18(12):1373-8. PubMed ID: 21895884 [Abstract] [Full Text] [Related]
15. Understanding Parkinson's disease: an update on current diagnostic and treatment strategies. Pahwa R. J Am Med Dir Assoc; 2006 Sep 05; 7(7 Suppl 2):4-10. PubMed ID: 17948613 [Abstract] [Full Text] [Related]
16. The patient's perspective: The effect of levodopa on Parkinson symptoms. Zach H, Dirkx M, Pasman JW, Bloem BR, Helmich RC. Parkinsonism Relat Disord; 2017 Feb 05; 35():48-54. PubMed ID: 27919585 [Abstract] [Full Text] [Related]
17. Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial. PD Med Collaborative Group, Gray R, Ives N, Rick C, Patel S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE. Lancet; 2014 Sep 27; 384(9949):1196-205. PubMed ID: 24928805 [Abstract] [Full Text] [Related]
18. Re-emergent Tremor in Parkinson's Disease: Evidence of Pathologic β and Prokinetic γ Activity. Ding H, Nasseroleslami B, Mirzac D, Isaias IU, Volkmann J, Deuschl G, Groppa S, Muthuraman M. Mov Disord; 2024 May 27; 39(5):778-787. PubMed ID: 38532269 [Abstract] [Full Text] [Related]
19. Ropinirole in the treatment of early Parkinson's disease: a 6-month interim report of a 5-year levodopa-controlled study. 056 Study Group. Rascol O, Brooks DJ, Brunt ER, Korczyn AD, Poewe WH, Stocchi F. Mov Disord; 1998 Jan 27; 13(1):39-45. PubMed ID: 9452324 [Abstract] [Full Text] [Related]
20. Wearing off: A complex phenomenon often poorly recognized in Parkinson's disease. A study with the WOQ-19 questionnaire. Pistacchi M, Gioulis M, Sanson F, Marsala SZ. Neurol India; 2017 Jan 27; 65(6):1271-1279. PubMed ID: 29133700 [Abstract] [Full Text] [Related] Page: [Next] [New Search]